HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia.

AbstractRATIONALE:
Group II metabotropic glutamate receptor (mGluR) agonists represent a novel approach to the treatment of schizophrenia. Inasmuch as the peptide neurotransmitter N-acetylaspartylglutamate (NAAG) activates these receptors, NAAG peptidase inhibitors conceptually represent a parallel path toward development of new antipsychotic drugs. While group II agonists are effective in several animal models of schizophrenia, they are reported to lack efficacy in moderating the effects of phencyclidine (PCP) on prepulse inhibition of acoustic startle in animal models of sensory processing deficits found in this disorder.
OBJECTIVE:
The objective of this study was to re-examine the efficacy of a group II metabotropic glutamate agonist and NAAG peptidase inhibitors in prepulse inhibition models of schizophrenia across two strains of mice.
METHODS:
The method used was an assay to determine the efficacy of these drugs in moderating the reduction in prepulse inhibition of acoustic startle in mice treated with PCP and D: -amphetamine.
RESULTS:
The group II agonist LY354740 (5 and 10 mg/kg) moderated the effects of PCP on prepulse inhibition of acoustic startle in DBA/2 but not C57BL/6 mice. In contrast, two NAAG peptidase inhibitors, ZJ43 (150 mg/kg) and 2-PMPA (50, 100, and 150 mg/kg), did not significantly affect the PCP-induced reduction in prepulse inhibition in either strain.
CONCLUSIONS:
These data demonstrate that the efficacy of group II agonists in this model of sensory motor processing is strain-specific in mice. The difference between the effects of the group II agonist and the peptidase inhibitors in the DBA/2 mice may relate to the difference in efficacy of NAAG and the agonist at mGluR2.
AuthorsCaterina P Profaci, Kristyn A Krolikowski, Rafal T Olszewski, Joseph H Neale
JournalPsychopharmacology (Psychopharmacology (Berl)) Vol. 216 Issue 2 Pg. 235-43 (Jul 2011) ISSN: 1432-2072 [Electronic] Germany
PMID21327758 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • 2-(phosphonomethyl)pentanedioic acid
  • Bridged Bicyclo Compounds
  • Excitatory Amino Acid Agonists
  • Organophosphorus Compounds
  • Receptors, Metabotropic Glutamate
  • ZJ43
  • Urea
  • Glutamate Carboxypeptidase II
  • Phencyclidine
  • eglumetad
  • Dextroamphetamine
Topics
  • Animals
  • Bridged Bicyclo Compounds (administration & dosage, pharmacology)
  • Dextroamphetamine
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Excitatory Amino Acid Agonists (administration & dosage, pharmacology)
  • Glutamate Carboxypeptidase II (antagonists & inhibitors)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Organophosphorus Compounds (administration & dosage, pharmacology)
  • Phencyclidine
  • Receptors, Metabotropic Glutamate (agonists)
  • Reflex, Startle (drug effects)
  • Schizophrenia (drug therapy, physiopathology)
  • Species Specificity
  • Urea (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: